Analysis of Rosiglitazone therapy on adipose tissue in type 2 diabetic patients

ABSTRACT: The goal of this study was to analyse the effect of a 12 weeks treatment with rosiglitazone on gene expression in adipose tissue of type 2 diabetic patients. Diabetic patients were treated with rosiglitazone, agonist of PPAR gamma, during 12 weeks. Adipose tissue biopsies were taken before and after the treatment.

ORGANISM(S): Homo sapiens

PROVIDER: GSE12793 | GEO | 2018/04/20

REPOSITORIES: GEO